Association between elevated serum REG Iα levels and eGFR decline in patients with chronic kidney disease: a cross-sectional study in eastern China
The study was approved by the Ethics Committee of Zhongda Hospital (approval number: 2022ZDSYLL204-P01) and conducted in compliance with the Helsinki Declaration. The clinical trial was registered under ChiCTR2300072247.
Authors
- Xiangyun Zhu (ORCID: https://orcid.org/0000-0002-7605-6700)
- Xiaodong Wu (ORCID: https://orcid.org/0000-0002-1031-5319)
- Rolf Graf (ORCID: https://orcid.org/0000-0001-7449-7302)
- Nan Huang (ORCID: https://orcid.org/0009-0002-1138-8541)
- Xi Huang (ORCID: https://orcid.org/0000-0002-7177-7525)
- Xiuxiu Hu
- Jianling Bai (ORCID: https://orcid.org/0000-0002-9845-5198)
- Sheng Chen (ORCID: https://orcid.org/0000-0003-3720-9724)
- Ling Li (ORCID: https://orcid.org/0000-0003-0083-6978)
- Bin Wang (ORCID: https://orcid.org/0000-0002-7166-0482)
- Jinfang Sun
- Ping-Sheng Chen
- Zhiyi Shu
- Hui Wang (ORCID: https://orcid.org/0009-0005-3483-0621)
Institutions
- University Hospital of Zurich (CH)
- Zhongda Hospital Southeast University (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-086874
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Southeast University